TOTAL NEOADJUVANT THERAPY
Clinical trials for TOTAL NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new TOTAL NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for TOTAL NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (PD-1 inhibitor) to a standard treatment plan (short-course radiation, chemotherapy, and a targeted therapy) can improve outcomes for people with locally advanced rectal cancer. About 104 adults with a specific type of rectal …
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New combo therapy aims to boost rectal cancer outcomes
Disease control Recruiting nowThis study tests whether adding immunotherapy to standard treatment (radiation and chemotherapy before surgery) can improve outcomes for people with locally advanced rectal cancer. It also compares a shorter course of radiation to a longer one. About 444 adults aged 18-75 with a …
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 22, 2026 13:51 UTC